低风险骨髓质瘤 (MDS) 患者的管理
Josephine Lucero1, Salman Al-Harbi1, Karen W L Yee1,2
1Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, 700 University Avenue, 6th Floor, Toronto, ON M5G 1Z5, Canada.
Current oncology (Toronto, Ont.)
|July 28, 2023
概括
骨髓质瘤 (MDS) 的分类和预后的最新更新,包括IPSS-M得分,有助于个性化治疗低风险的MDS患者,重点是使用新疗法治疗贫血.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 基因组学就是基因组学.
背景情况:
- 骨髓发育性瘤 (MDS) 是一种克隆性血液学疾病,其特征是发育不良,无效的造血和细胞衰竭.
- 最近的进展包括更新的分类 (世卫组织第5版,ICC) 和IPSS-M预后得分.
- 这些发展增强了MDS的个性化治疗策略.
研究的目的:
- 总结最近在MDS分类和预测方面的最新更新.
- 审查当前和新兴的治疗选择,较低风险的MDS.
- 为较低风险的MDS患者提供临床管理指南.
主要方法:
- 更新的分类系统的审查 (世卫组织,ICC).
- 国际预测评分系统-分子 (IPSS-M) 的分析.
- 目前和正在研究的低风险MDS治疗方法的摘要.
主要成果:
- 新的分类系统和IPSS-M改善了风险分层.
- 已批准的治疗方法,如卢斯帕特塞普特和德西塔宾/塞扎祖里丁,为治疗提供了新的途径.
- 新兴药物 (imetelstat,口服azacitidine) 在临床试验中显示出有希望的结果.
结论:
- 更新的分类和IPSS-M有助于制定量身定制的治疗决策.
- 专注于改善MDS风险较低的细胞衰竭,特别是贫血.
- 扩大治疗选择需要全面了解MDS管理.
相关概念视频
Bone Marrow Sampling and Transplants
360
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
360
Mitral Valve Prolapse III: Nursing Management
17
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
17
Differentiation of Common Myeloid Progenitor Cells
3.2K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.2K


